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GENETIC TESTING AND EMPLOYMENT LITIGATION
HARRY ZANVILLE1
Thank you very much, and just as a preface, I really appreciate and am a bit
humbled to be invited to this conference. I’m surrounded by such bright people and
such committed people. It’s just a great experience for me.
Most major policy problems have their own vocabulary of context, and this case
that I was involved in is no exception. About 60 percent of current reported
occupational illnesses are from repetitive motion injuries. It’s such a huge problem
in American industry that about 80 percent of these cases, which are general
laydown kind of cases, are contested in Workers’ Compensation or in Federal
Employers’ Liability Act settings.2
This fact is compounded by the fact that most major employers believe they have
plenary power to conduct medical tests, obtain medical information and use that
information without restraint, kind of a provocative statement, but if you think about
it it’s true.
I think you’ll also find it’s provocative but true that many people who act as
occupational medical providers, health insurance administrators, treating medical
providers and even geneticists do not know or even respect the privacy rights of
individual workers.
There are a number of very surprising studies that talk about the absolute
amenability of these healthcare providers to turn over information without authority.
So when we go over those kinds of facts and in some cases partial assumption
together, you end up in a context where bad things can happen to good people, and
that’s what the Burlington Northern Santa Fe (BNSF) case really was about.
You should be aware that the case started, I think, when Athena Diagnostics
doing some very interesting advertising. Athena Diagnostics is owned by Elan
Pharmaceuticals Company, the third biggest pharmaceutical company in the world.
Elan has invested millions of dollars in preparing to engage in the sale of genetic
testing products and the sale of arguably treatment for genetic-based diseases.
Athena, whose claim to genetic fame first was their home testing kit for
Alzheimer’s disease advertised by direct mail over the Internet and in magazines had
tests to predict who would get carpal-tunnel syndrome. Their research was based on,
believe it or not, scientific work done by Dr. Philip Chance. Phil Chance is a
wonderful guy who has been inflicted by genetic disease himself and who, according
to Dr. Chance,’s research, was totally perverted by the people at Elan
Pharmaceutical.

1
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Their advertising was on a website. You can look it up if you’d like to at
http://www.athenadiagnostics.com, some wonderfully descriptive stuff where they
talk about their pressure palsy neuropathy tests, and then they talked about it in very
glowing terms. If you have carpal-tunnel syndrome, folks, we have the highest level
of accuracy available in testing. Tests, of course, developed by Dr. Philip Chance
and his colleagues, and they got a little picture, which I like to refer to as the genetic
tarot card. It kind of looks like a little card, and it talks in scientific terms, but just
enough that non-scientific people like occupational medical providers could
understand, and they talk about, if you’ve got some of your workers who present
with carpal-tunnel syndrome, that’s an indication for testing.
Isn’t this a wonderful test, and they give you all sorts of reasons why you should
do this. Of course, these tests are wonderfully affordable, you know, somewhere
between $1,000 or $3,000. They also engage in direct mailings, direct cold calls to
corporations because they know that carpal-tunnel syndrome, repetitive injury stuff
is a hot deal. There’s a lot of money at stake.
Well, like all advertisers, sometimes the right person hears the right information.
The Burlington Northern, like most of the nation’s class one railroads, has a huge
carpal-tunnel problem. They [cut] back on their maintenance forces by two-thirds
and they’re actually maintaining more track than they ever have because of their
merger activity.
It’s so bad on the railroads, that over a million dollars of lobbying was spent by
the American Association of Railroads (AAR) to get an exemption from the then
existing, the new OSHA ergonomics requirements. If they just kind of waited, they
didn’t have to spend that kind of money, but they nonetheless did. So they were
exempted.
The Federal Railway Administration (FRA) has regulations that require accurate
and complete reporting of occupational-related claimed injuries, not just injuries, just
claims of injuries, and the nation’s class one railroads simply lied to the FRA. They
have said consistently as a group since about 1994, 1995, there is no more carpaltunnel in the nation’s railroads. It’s the medical breakthrough that should have been
reported in Science Magazine or in the New England Journal of Medicine, but it
wasn’t, and that’s a little surprising. But that’s how it is on the railroad. Then you
say, “well, how could that possibly be?”
So that was the question I was asking of George Gavalla, who is director of
safety at the FRA, when I got his reports that they did not want to release. But I
found an ex-OSHA employee who was willing to give me the information, and
there’s a set of data, on all the AAR members: Norfolk Southern, the last reported
carpal-tunnel injury was 1991; the Soo Line Railroad, their last one was 1993;
Union Pacific, their last one was 1994, and it goes on, and the data doesn’t lie.
These are official documents, you know, federal documents. And the Burlington
Northern in 1995 reported five cases of carpal-tunnel and that was the last time they
reported any.
So it was wonderful that there was no more carpal-tunnel to worry about on the
Burlington Northern Railroad. They had, however, some problems because,
notwithstanding the fact they didn’t have carpal-tunnel, they were settling carpeltunnel cases like crazy with FELA.
There’s one firm in Kansas City that in the year 2000, settled 5,000 cases of
carpel-tunnel. Now, keep in mind, at the FRA, there’s a $5,000 minimum fine for
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not reporting an occupational injury or illness. It didn’t seem to matter to them.
5,000 cases in one firm alone. Well, how do you deal with that?
Well, they decided to use their occupational medical people to resolve their
issues, and they were going to start to do this by genetic testing because they saw the
Athena ads and they figured, well, they must be able to address them, and they had
125 cases they were just sure could have a genetic basis, and so even though there
was no problem with genetic testing – no problem with carpal-tunnel, they decided
that they were going to do genetic testing for the cause of these non-existing carpaltunnel injuries.
We say well, how would a big corporation like BNSF ever be motivated to do
such things. There’s actually a little history. I mean, not all employers are purely
benevolent. There’s a case entitled Sheet Metal Workers International Union v.
Burlington Northern, which is an Eighth Circuit case, 736 Fed. 2d, 1250.
In 1984, the Burlington Northern was caught on their railroad injury cases using
their claims representatives, company people, to threaten the workers. If they hired a
lawyer or retained a lawyer, it would jeopardize job security, promotions and cash
advances. This was documented.
The Eighth Circuit described the conduct of the railroad as “disturbing and
reprehensible,”3 but found they were isolated incidents and surely couldn’t represent
what the corporation really was all about. They were trying to save money. That’s
what they were doing. Most of these railroad workers have a seventh grade
education, one-third of them don’t speak English. About 80 percent are not
represented by lawyers when they settle their FELA claims.
So this is the kind of company and the history, the pedigree, that we’re dealing
with. So is it a surprise that the BNSF would want to be engaged in genetic testing?
Not really.
When we blew the whistle with the FRA over the genetic testing and turned to
the FRA and said, “why isn’t this being reported,” the FRA questioned BNSF’s
officials, and according to the report back, and I quote, BNSF spokesman, Richard
Russack, says, “The railroad does not report any of its claimed carpal-tunnel cases
because the company determined that none of them were work-related.”
It’s, by the way, the same reason they don’t report asbestos cases,
mesotheliomas, because, after all, these guys are working on brakes in their home
garages, not on locomotive brakes. You know, it’s okay.
By the way, the test that was done by Dr. Chance related to adolescents who,
without any history of industrial repetitive-motion work, presented at the age of
seven or eight with carpal-tunnel syndrome.
It had nothing to do with people who had 20 to 25 years of working on the rails
with hand grinders and hydraulic jackhammers. That’s the research that Athena was
basing their work on.
There’s also, and I’ll take the liberty of quoting from a deposition of Dr. Girard,
who is the Chief Medical Officer for the BNSF, who describes his attitude towards
ethics and privacy in a deposition that was taken before our case.
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He says – regarding the question of confidentiality, he says, “Personally, I will
call doctors and I’ll ask doctors questions about person’s functional ability and
restrictions, as that information is necessary for me to determine fitness for duty.”
And the question from the lawyer, “Would you do that without a medical
authorization from the employee”, and the answer was “Yes.” And then the question
is, “Well, then in what states would you do that without medical authorization from
an employee?” Answer: “I do it in any state the doctor resides.” So the company
does business in 28 states, and they don’t care about privacy at all.
The question was asked, “Could a railroad compel a man on the subject of being
fired if he refuses to agree to a medical examination which does not comport with
common sense, and which was not consistent with medical standards? Could that
employee be fired for not going?” The answer is, “Yes, it’s within the realm of
possibility.”
The doctor, however, admitted that he did believe that he has an ethical
responsibility, and that his responsibility is tied to a code of ethical conduct to those
people engaged in occupational medicine, which is ironic because the society,
professional society for people in occupational medicine has a specific provision that
says, “You cannot engage in genetic testing without a written informed consent,” but
he didn’t pay attention to that rule.
The doctor also at the end of the deposition talked about his job as the
occupational medical provider for the BNSF, and he indicated that “The money we
pay for the tort system is the cost of doing business and I want to try to keep it at a
minimum.”
So their motives are not to pay injury claims, not necessarily do what’s in the
interest of the injured worker. They engaged in this program, and one of the things
they did is they sent a letter out to their local medical providers, and the letter says to
them, “We are sending you a kit to do blood samples for genetic tests for pressure
palsy. It’s going to be sent to a reference laboratory with kits provided by us. Please
leave any decision about work-relatedness of these injuries to us. We will complete
an ergonomic risk factor assessment independently. We only want you to confirm
the diagnosis of carpal-tunnel and evaluate evidence of contributing health
conditions, but not work-related.”
In other words, “Don’t tell us what really caused the injury, just tell us what we
want to hear.” That’s the instructions to the doctor who is hands-on with the patients
of these various states and, of course, the company that was employing these tertiary
doctors when asked the question of what do you tell the employee, says, “Well, we
do not explain or discuss the purpose of the test or evaluation of the employees
unless specifically instructed to do so by the employers who sent the employee.” It’s
a nice circle.
What we found out in this case is not one of the local doctors, not one of the local
hospital facilities, not one of the local testing lab, nobody ever said, “Gee, this is
wrong. We can’t do this.” Everybody in the system thought, “We know who is
paying the bills, and we’re going to do what they want to do.”
And so what happened was the Burlington Northern did, in fact, commence to do
first secret genetic testing of injured workers and then when they were caught at it
says to the worker who caught them, Gary Avary and his wife, “Fine, we’re just
going to coerce you: you don’t do it, you’re fired.”
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That’s when I was contacted. We stepped in, found the right place to go to court
and were successful with, I will say, the help of a very large dog, the EEOC. If you
want to get in a fight with a bully, put yourself in with a really good junkyard dog.
COMMISSIONER MILLER: Thank you, I think.
MR. ZANVILLE: And Commissioner Miller and his troops rallied to the cause
and we are very grateful to them, because I don’t think we would have achieved the
level of success we did in the case as quickly without their help.
We were able to marshal the most wonderful cadre of professional geneticists
and medical care people that you could ever imagine. I have never been involved in
a case in all of the years I practiced law where people came out of the woodwork at
no cost and said, “We want to provide for free any expertise that we can.” It’s
incredible.
Francis Collins at NIH, at the Human Genome Project; Tony Holtzman at Johns
Hopkins, Whylie Burke, University of Washington Paul Billings. It was incredible
and heartwarming, and so to the extent that someone was looking for Harry Potter
before, those are those Harry Potter kind of people, because they stood up and said,
this is the right thing to do and we’re all going to stand in line to do the right thing.
It was amazing.
And in the process of all of this, the media generated a lot of pressure on the
Burlington Northern and its shareholders, and when the case got to be reported in
five continents on every form of media you could imagine, Burlington Northern paid
serious attention to the case and did the right thing.
There is a dynamic that, I think, is important. If someone knows how to turn this
machine on, I’d like to use what I think might be a good diagram. Hopefully you all
can see that, if I get out of the way. One of the things that we’ve thought about a lot
is how can these cases actually happen, and the root of the problem, it seems to me at
this point is, that the occupational medical provider in large corporations is the key to
this.
There are lots of reasons why occupational medical departments want to engage
in genetic testing. Some of them are to benefit themselves; that is, they want to be
thought of as cutting edge kind of people. These are men and women who really
think of themselves as kind of just ahead of the curve and want to go and do neat
stuff. And what is neater than genetic research and finding out how to prevent
injuries? So you have people who want to be ahead of the curve.
Then you have another set of people who don’t want to be criticized for not being
ahead of the curve, and so get positive and negative reasons for wanting to do what
truthfully is medical experimentation; that is, collecting data, doing medical tests,
which are probably unnecessary because they’re not going to lead to anything useful,
not telling patients about them, and that’s the stuff that is prohibited by the
Nurenberg code and the Helsinki principles embodied in international law, and in
California, it’s statutory.
So you have sort of personal kinds of issues, and so that’s part of one of the
circles there, which is, medical decisions are intended to benefit the occupational
medical provider.
You then have another group of medical decisions that can be intended to benefit
the employer. That is, there are some occupational doctors, including, I believe, Dr.
Jarrard in our case who really took the position of, “Geez, why don’t we just cut out
a lot of costs.” Why don’t we go get this data as best we can, and then go to these
uneducated workers who are unrepresented by counsel and say, “We’re really sorry
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about the carpal-tunnel you’ve got, but, you know, FELA is a negligence-based
system. The fault was your parents. We didn’t do this to you, and here, see, it’s all
in writing, and if they didn’t like it, go and use the collective bargaining process to
try to resolve this. You have a right to go hire your own geneticists, even though you
only make $18,000 a year and you live in Yankton, South Dakota and there’s no
geneticist for 900 miles. Okay. Go ahead and deal with this administratively.”
Well, you know it’s not going to happen, and the local FELA lawyers can’t help.
They’re out of their element. They have no idea.
So there’s lot of ways that the circle of medical decisions that are intended to
benefit the employer, the occupational medical providers, sort of militate, and, of
course, then you’ve got that subset, and I would like to think it’s a narrow subset, of
medical decisions that are intended to harm the employee’s interests.
There are a number of cases where you will find that doctors have taken a
particular animosity to certain people, and it happened in our people with two of the
employees who were specifically threatened, and it’s pretty amazing. I’ve been
given the stop sign.
Let me just share with you anecdotally one thing. The biggest trade magazine for
the railroad industry is Traffic World Magazine, and Traffic World concluded in one
of their articles after seeing what happened in our case and said two things: Maybe
BNSF was using gene testing to discover the predisposition to become the ideal
railroad employee, retires at 65 and dies within six months to save the company
retirement fund. And they followed that up by saying, test for this, if the BNSF is so
intent on testing the genes of its employees, we suggest they forget about identifying
genes that predict carpal-tunnel and instead use their test to locate people who can
actually track a shipment and tell the customer where their freight is.4
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